The Effects of Irvingia gabonensis Seed Extract Supplementation on Anthropometric and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis

References

• WHO. Obesity and overweight. Geneva: World Health Organization; 2018 [accessed 2018 Aug 6]. http://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.
   Google Scholar
• Blanck HM, Serdula MK, Gillespie C, Galuska DA, Sharpe PA, Conway JM, Khan LK, Ainsworth BE. Use of nonprescription dietary supplements for weight loss is common among Americans. J Am Diet Assoc. 2007;107(3):441–447. doi:10.1016/j.jada.2006.12.009.
   PubMedGoogle Scholar
• Persistence Market Research. North America to witness strong growth in the global weight loss dietary supplements market during the forecast period 2017–2026. New York (NY): Persistence Market Research; 2017 [accessed 2018 Aug 6]. https://www.persistencemarketresearch.com/mediarelease/weight-loss-dietary-supplements-market.asp.
   Google Scholar
• Grand View Research. Dietary supplements market size, share & trend analysis report by ingredient (botanicals, vitamins, minerals, amino acids, enzymes), by product, by application, by end-use, and segment forecasts, 2018–2024. San Francisco (CA): Grand View Research; 2018.
   Google Scholar
• Sun J, Chen P. UHPLC/HRMS analysis of African mango (Irvingia gabonensis) seeds, extract and related dietary supplements. J Agric Food Chem. 2012;60(35):8703–8709. doi:10.1055/s-0032-1320571.
   PubMed Web of Science ®Google Scholar
• Lee MH, Nam D-E, Kyung KO, Shim TJ, Kim JH, Lee JM. Anti-obesity effects of African mango (irvingia gabonesis, IGOB 131™) extract in leptin-deficient obese mice. J Korean Soc Food Sci Nutr. 2014;43(10):1477–1483. doi:10.3746/jkfn.2014.43.10.1477.
   Google Scholar
• Nangue TJ, Womeni HM, Mbiapo FT, Fanni J, Michel L. Irvingia gabonensis fat: nutritional properties and effect of increasing amounts on the growth and lipid metabolism of young rats wistar sp. Lipids Health Dis. 2011;10(1):43. doi:10.1186/1476-511X-10-43.
   PubMedGoogle Scholar
• Ngondi JL, Oben JE, Minka SR. The effect of irvingia gabonensis seeds on body weight and blood lipids of obese subjects in Cameroon. Lipids Health Dis. 2005;4(1):12.
   PubMedGoogle Scholar
• Wang L, Li L, Ran X, Long M, Zhang M, Tao Y, Luo X, Wang Y, Ma X, Halmurati U, et al. Ellagic acid reduces adipogenesis through inhibition of differentiation-prevention of the Induction of rb phosphorylation in 3T3-L1 adipocytes. Evid Based Complement Alternat Med. 2013;2013:1–11. doi:10.55/2013/287534.
   Google Scholar
• Goldfine AB, Kahn CR. Adiponectin: linking the fat cell to insulin sensitivity. Lancet. 2003;362(9394):1431–1432. doi:10.1016/S0140-6736(03)14727-7.
   PubMed Web of Science ®Google Scholar
• Oben JE, Ngondi JL, Blum K. Inhibition of Irvingia gabonensis seed extract (OB131) on adipogenesis as mediated via down regulation of the PPARgamma and leptin genes and up-regulation of the adiponectin gene. Lipids Health Dis. 2008;7(1):44. doi:10.1186/1476-511X-7-44.
   PubMedGoogle Scholar
• Onakpoya I, Davies L, Posadzki P, Ernst E. The efficacy of Irvingia gabonensis supplementation in the management of overweight and obesity: a systematic review of randomized controlled trials. J Diet Suppl. 2013;10(1):29–38. doi:10.3109/19390211.2012.760508.
   PubMedGoogle Scholar
• Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0. Chichester (UK): The Cochrane Collaboration; 2011.
   Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–269. doi:10.7326/0003-4819-151-4-200908180-00135.
   PubMed Web of Science ®Google Scholar
• Shin CM, Park JY, Park JJ, Seo SW, Shim JI. Assessment of clinical safety and efficacy for weight loss supplements (Garcinia cambogia extract, Irvingia gabonensis seed extract) in humans. Seoul: National Evidence-based Healthcare Collaborating Agency; 2017.
   Google Scholar
• Wallace BC, Small K, Brodley CE, Lau J, Trikalinos TA, editors. Deploying an interactive machine learning system in an evidence-based practice center: abstrackr. Proceedings of the 2nd ACM SIGHIT International Health Informatics Symposium; 2012 Jan 28–30; Miami (FL): Association for Computing Machinery; 2012. p. 819–24.
   Google Scholar
• Cochrane. RoB 2: a revised cochrane risk-of-bias tool for randomized trials. Odense: Cochrane Methods Bias [accessed 2019 May 13]. https://methods.cochrane.org/bias/resources/rob-2-revised-cochrane-risk-bias-tool-randomized-trials.
   Google Scholar
• Méndez-del Villar M, González-Ortiz M, Martínez-Abundis E, Pérez-Rubio KG, Cortez-Navarrete M. Effect of Irvingia gabonensis on metabolic syndrome, insulin sensitivity, and insulin secretion. J Med Food. 2018;21(6):568–574. doi:10.1089/jmf.2017.0092.
   PubMed Web of Science ®Google Scholar
• Green S, Higgins J. Cochrane handbook for systematic reviews of interventions. London: The Cochrane Collaboration; 2011.
   Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560. doi:10.1136/bmj.327.7414.557.
   PubMed Web of Science ®Google Scholar
• Azantsa B, Kuate D, Chakokam R, Paka G, Bartholomew B, Nash R. The effect of extracts of Irvingia gabonensis (IGOB131) and dichrostachys glomerata (Dyglomera™) on body weight and lipid parameters of healthy overweight participants. Funct Foods Health Dis. 2015;5(6):200–208.
   Web of Science ®Google Scholar
• Ngondi JL, Etoundi BC, Nyangono CB, Mbofung CM, Oben JE. IGOB131, a novel seed extract of the West African plant Irvingia gabonensis, significantly reduces body weight and improves metabolic parameters in overweight humans in a randomized double-blind placebo controlled investigation. Lipids Health Dis. 2009;8(1):7. doi:10.1186/1476-511X-8-7.
   PubMedGoogle Scholar
• Oben JE, Ngondi JL, Momo CN, Agbor GA, Sobgui C. The use of a Cissus quadrangularis/Irvingia gabonensis combination in the management of weight loss: a double-blind placebo-controlled study. Lipids Health Dis. 2008;7(1):12. doi:10.1186/1476-511X-7-12.
   PubMedGoogle Scholar
• Alberti SG, Zimmet P, Shaw J, Grundy SM. The IDF Consensus Worldwide Definition of the Metabolic Syndrome. Brussels: International Diabetes Federation; 2005.
   Google Scholar
• Kim JY, Kim DB, Lee HJ. Regulations on health/functional foods in Korea. Toxicology. 2006;221(1):112–118. doi:10.1016/j.tox.2006.01.016.
   PubMed Web of Science ®Google Scholar
• Korean Ministry of Food and Drug Safety. Handbook of functional foods - body fat loss. Osong: Korean Ministry of Food and Drug Safety; 2012.
   Google Scholar
• Korean Ministry of Food and Drug Safety. Health Functional Foods Act, Act No. 13300 (2015).
   Google Scholar
• Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomized trials. Open Med 2010;4(1):60–68.
   Google Scholar